AVEO Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2012 – 2021)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.90-0.87-0.83-4.67-1.39-4.54-39.2510.22-3.47-1.64-17.88-4.54
Price/Sales ratio
17.2072.072.423.6814.8738.9938.673.3320.512.587.6138.99
Price/Book Value ratio
2.781.332.134.07-19.45-7.25-7.686.463.492.1818.00-19.45
Price/Cash Flow ratio
-3.13-1.10-0.80-3.84-1.20-15.42-8.35-32.88-3.25-1.75-22.91-15.42
Price/Free Cash Flow ratio
-2.86-1.05-0.65-3.84-1.20-15.42-8.35-32.88-3.22-1.75-22.91-15.42
Price/Earnings Growth ratio
0.00-0.040.010.06-0.03-0.070.42-0.040.00-0.020.35-0.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A100%100%100%100%100%100%79.31%87.81%83.13%100%
Operating Profit Margin
-578.84%-8035.88%-278.37%-65.31%-1168.70%-380.14%-468.79%-1.29%-645.90%-127.47%-35.92%-1168.70%
Pretax Profit Margin
-593.14%-8277.57%-291.00%-78.85%-1065.04%-856.63%-98.52%32.60%-591.19%-137.21%-42.59%-1065.04%
Net Profit Margin
-593.14%-8277.57%-291.00%-78.85%-1069.06%-857.96%-98.52%32.60%-591.19%-157.36%-42.59%-1069.06%
Effective Tax Rate
N/AN/A-0.18%1.78%-0.37%-0.15%N/AN/A-13.76%-14.68%N/A-0.37%
Return on Assets
-55.13%-73.13%-74.63%-37.00%-98.54%-129.53%-19.07%18.55%-53.18%-58.07%-28.68%-98.54%
Return On Equity
-96.17%-153.03%-255.94%-87.07%1398.17%159.51%19.57%63.23%-100.82%-133.36%-81.65%159.51%
Return on Capital Employed
-66.31%-90.4%-166.45%-44.15%-173.55%-159.40%-258.27%-1.26%-77.80%-57.21%-41.64%-173.55%
Liquidity Ratios
Current Ratio
4.874.101.463.252.541.561.542.393.86N/A2.371.56
Quick Ratio
4.633.991.463.252.541.561.542.393.865.502.291.56
Cash ratio
1.941.611.292.141.450.461.341.413.643.761.821.45
Days of Sales Outstanding
390.791.92K47.1489.04149.0419.36204.1920.6772.5892.11105.82105.82
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A127.5935.11N/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/A72.58219.7161.20N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/A990.92208.96159.98N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/A-918.3310.75-45.50N/A
Debt Ratios
Debt Ratio
0.420.520.290.230.510.360.680.310.210.000.710.51
Debt Equity Ratio
0.741.091.000.54-7.28-0.45-0.691.060.400.002.50-7.28
Long-term Debt to Capitalization
0.130.110.300.301.19-0.82-1.370.290.26N/A0.480.48
Total Debt to Capitalization
0.170.210.500.351.15-0.82-2.320.510.280.000.570.57
Interest Coverage Ratio
-31.13-30.66-16.21-3.49-15.08-11.26-11.87-0.20-24.22N/A7.02-15.08
Cash Flow to Debt Ratio
-4.06-4.39-2.62-1.92-2.21-1.03-1.31-0.18-2.68-5.20K-0.58-2.21
Company Equity Multiplier
1.742.093.422.35-14.18-1.23-1.023.401.892.293.50-14.18
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-5.48-65.27-2.99-0.95-12.35-2.52-4.62-0.10-6.31-1.47-0.33-12.35
Free Cash Flow / Operating Cash Flow Ratio
1.091.041.231.001.001111.00111
Cash Flow Coverage Ratio
-4.06-4.39-2.62-1.92-2.21-1.03-1.31-0.18-2.68-5.20K-0.58-2.21
Short Term Coverage Ratio
-15.52-8.12-4.62-8.87-14.62N/A-7.69-0.30-26.65-5.20K-1.97-14.62
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A